Safety Shot Appoints New Director, Announces Officer Compensation
Ticker: BNKK · Form: 8-K · Filed: Sep 4, 2025 · CIK: 1760903
Sentiment: neutral
Topics: board-changes, executive-compensation, officer-appointment
TL;DR
Board shakeup at Safety Shot: Dr. Wild out, Dr. Smith in. Officer pay details also released.
AI Summary
On August 29, 2025, Safety Shot, Inc. filed an 8-K report detailing the departure of director Dr. David G. Wild, effective August 23, 2025. The company also announced the appointment of Dr. Michael J. R. Smith as a new director, effective August 29, 2025. Additionally, the filing disclosed compensatory arrangements for certain officers.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy and governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in directorship and executive compensation can introduce uncertainty regarding future strategic direction and operational stability.
Key Players & Entities
- Safety Shot, Inc. (company) — Registrant
- Dr. David G. Wild (person) — Departing Director
- August 23, 2025 (date) — Effective date of director's departure
- Dr. Michael J. R. Smith (person) — Appointed Director
- August 29, 2025 (date) — Effective date of director's appointment
FAQ
Who has departed from Safety Shot, Inc.'s board of directors?
Dr. David G. Wild has departed from Safety Shot, Inc.'s board of directors, with his departure effective August 23, 2025.
Who has been appointed as a new director to Safety Shot, Inc.'s board?
Dr. Michael J. R. Smith has been appointed as a new director to Safety Shot, Inc.'s board, effective August 29, 2025.
What is the effective date of the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing is dated August 29, 2025.
What specific items are covered in this Form 8-K filing?
This Form 8-K covers the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, as well as financial statements and exhibits.
What was Safety Shot, Inc.'s former company name?
Safety Shot, Inc. was formerly known as Jupiter Wellness, Inc. (name change effective June 15, 2020) and prior to that, CBD Brands, Inc. (name change effective December 6, 2018).
Filing Stats: 500 words · 2 min read · ~2 pages · Grade level 11.8 · Accepted 2025-09-04 16:26:33
Key Financial Figures
- $8.50 — isable for one share of Common Stock at $8.50 per share SHOTW The Nasdaq Stock Ma
Filing Documents
- form8-k.htm (8-K) — 44KB
- 0001641172-25-026592.txt ( ) — 249KB
- shot-20250829.xsd (EX-101.SCH) — 4KB
- shot-20250829_def.xml (EX-101.DEF) — 26KB
- shot-20250829_lab.xml (EX-101.LAB) — 36KB
- shot-20250829_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
From the Filing
UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C., 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 29, 2025 SAFETY SHOT, INC. (Exact name of registrant as specified in charter) Delaware 001-39569 83-2455880 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 18801 N Thompson Peak Pkwy Ste 380 , Scottsdale , AZ 85255 (Address of principal executive offices) (Zip Code) (561) 244-7100 (Registrant's telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock SHOT The Nasdaq Stock Market LLC (The Nasdaq Capital Market) Warrants, each exercisable for one share of Common Stock at $8.50 per share SHOTW The Nasdaq Stock Market LLC (The Nasdaq Capital Market) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 ( 240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mart if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Resignation of Chief Operating Officer On August 29th, 2025, David Sandler resigned as the Chief Operating Officer of Safety Shot, Inc. (the "Company") effective as of such date. Mr. Sander's resignation was not due to any disagreement with the Company or its Board of Directors or any matter relating to the Company's operations, policies or practices. As of September 1, 2025, Mr. Sandler began a six month term as a consultant for the Company. Section 9 - Financial Statements and Exhibits Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 4, 2025 SAFETY SHOT, INC. By: /s/ Jarrett Boon Jarrett Boon Chief Executive Officer